Home Members Only Search About Us Store FASEB Member Directory

 the-aps.org>meetings>eb

advertising
awards
careers and mentoring
chapters
committees
education
meetings
membership
news archives
press room
public affairs
publications
sections and groups
sites of interest
trainees

9560 rockville pike, bethesda, MD 20814-3991
 

 


Hypoxia and Cancer
Sponsored by APS Hypoxia Group
Oxidative Stress/Hypoxia Track

Monday, April 30 — 8:00-10:00 AM
Washington, DC Convention Center — Room 146C
 
Chaired:

Gregg L. Semenza, Johns Hopkins Univ. Sch. of Med.

Human cancers are characterized by intratumoral hypoxia that results from dysregulated cell proliferation.  Physiological responses triggered by hypoxia impact on all critical aspects of cancer progression, including immortalization, transformation, differentiation, genetic instability, angiogenesis, metabolic adaptation, autocrine growth factor signaling,  invasion, metastasis, and resistance to therapy.  This symposium will focus on the cellular and molecular mechanisms by which cancer cells coopt adaptive physiological responses to hypoxia, particularly those that are mediated by the transcriptional activator hypoxia-inducible factor 1.

8:00 AM

The role of hypoxia-inducible factor 1 in human cancer.
Gregg L. Semenza
, Johns Hopkins Univ. Sch. of Med.
 

8:30 AM

The role of hypoxia in Akt-mediated melanocyte transformation.
Marianne Broome-Powell
, Stanford Univ.
 

9:00 AM

The role of hypoxia in tumor cell differentiation.
Lorenz Poellinger
, Karolinska Inst.
 

9:30 PM

Mechanisms of hypoxia-induced resistance to radiation therapy.
Mark W. Dewhirst
, Duke Univ. Med. Ctr.